NXGM yields 1000000.00% · PFE yields 6.13%● Live data
📍 NXGM pulled ahead of the other in Year 1
Combined, NXGM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXGM + PFE for your $10,000?
NexGen Mining, Inc., a junior mining company, engages in the exploration, mining, and production of precious metals. The company primarily explores for gold, silver, copper, lead, zinc, and other precious and base metals. It holds interests in the Old Dominion mine situated north of Reno, Nevada; the Koegel Hills property that consists of 10 unpatented claims encompassing 200 acres located in Mineral County, Nevada; the Four Mile Basin gold property, which comprises two unpatented claims consisting of 20 acres and is situated in Nye County, Nevada; the Gold Star property located in Mineral County, Nevada; and the Pyramid mine located Nevada, as well as in the Paradise Peak mine. NexGen Mining, Inc. was formerly known as Brilliant Sands Incorporated and changed its name to NexGen Mining, Inc. in January 2018. The company was incorporated in 1888 and is based in Reno, Nevada. NexGen Mining, Inc. is a former subsidiary of 1824455 Alberta Ltd.
Full NXGM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.